Madison Square Garden Sports Corp. (MSGS) Stock Analysis
MSGS is a rare “trophy-asset” arbitrage: buy the Knicks and Rangers at a steep public-market discount, with a spin-off, NBA media windfall and expansion fees as the catalysts—while the 2028 Garden permit and RSN disruption remain the swing risks.
Overview
Madison Square Garden Sports Corp owns the New York Knicks (NBA) and New York Rangers (NHL) plus related development teams and the MSG Training Center, forming a premier live-sports asset base concentrated in the highest-value U.S. media market. FY2025 revenue reached ~$1.11B, reflecting strong demand and playoff-driven upside; growth came from higher ticketing (+$56M) and premium/sponsorship growth (+$38.3M), while media revenue remained foundational at ~$394.4M. The model blends recurring contractual income (national/local media, long-term suites, sponsorships) with high operating leverage to playoff games. Strategically, MSGS is positioned to benefit from the NBA’s new $76B media cycle and potential NBA expansion payouts, while management is attempting to address a long-standing valuation gap via an announced exploration of spinning off the Knicks and Rangers into separate public companies. The investment debate centers on whether these catalysts can overcome governance and regulatory overhangs (dual-class Dolan control and the 2028 Garden permit).